{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:28:19Z","timestamp":1757611699575,"version":"3.44.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","sleep.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Clinics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jsmc.2025.05.003","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T23:43:23Z","timestamp":1749771803000},"page":"407-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transdermal, Infusion, and Surgical Therapies and Effect on Sleep Dysfunction in Parkinson\u2019s Disease"],"prefix":"10.1016","volume":"20","author":[{"given":"Karolina","family":"Pop\u0142awska-Domaszewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raslan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riaan","family":"van Coller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyoumars","family":"Ashkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haider","family":"Dafsari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosabel","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Ray","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jsmc.2025.05.003_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/mds.27626","article-title":"EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson\u2019s disease","volume":"34","author":"Dafsari","year":"2019","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.jsmc.2025.05.003_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-0404.1999.tb00732.x","article-title":"Nocturnal subcutaneous apomorphine infusion in Parkinson\u2019s disease and restless legs syndrome","volume":"100","author":"Reuter","year":"2009","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.003_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40263-020-00788-4","article-title":"Rotigotine transdermal patch for motor and non-Motor Parkinson\u2019s disease: a review of 12 years\u2019 clinical experience","volume":"35","author":"Raeder","year":"2021","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.003_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.23441","article-title":"Rotigotine effects on early morning motor function and sleep in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled study (RECOVER)","volume":"26","author":"Trenkwalder","year":"2010","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.003_bib5","article-title":"Rotigotine transdermal patch and sleep in Parkinson\u2019s disease: where are we now?","volume":"3","author":"Rosa-Grilo","year":"2017","journal-title":"\u2019NPJ Parkinson\u2019s Disease"},{"issue":"12","key":"10.1016\/j.jsmc.2025.05.003_bib6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00702-010-0506-4","article-title":"Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson\u2019s disease","volume":"117","author":"Giladi","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jsmc.2025.05.003_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.sleep.2019.05.002","article-title":"The efficacy and safety of rotigotine transdermal patch for the treatment of sleep disorders in Parkinson\u2019s disease: a meta-analysis","volume":"61","author":"Fei","year":"2019","journal-title":"Sleep Med"},{"key":"10.1016\/j.jsmc.2025.05.003_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2017.08.010","article-title":"Rotigotine for nocturnal hypokinesia in Parkinson\u2019s disease: quantitative analysis of efficacy from a randomized, placebo-controlled trial using an axial inertial sensor","volume":"44","author":"Bhidayasiri","year":"2017","journal-title":"Parkinsonism Relat Disorders"},{"key":"10.1016\/j.jsmc.2025.05.003_bib9","article-title":"Transdermal rotigotine improves sleep fragmentation in Parkinson\u2019s disease: results of the multicenter, prospective SLEEP-FRAM study","volume":"2015","author":"Pagonabarraga","year":"2015","journal-title":"Parkinsons Dis"},{"issue":"10","key":"10.1016\/j.jsmc.2025.05.003_bib10","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1185\/03007995.2011.611630","article-title":"Rotigotine transdermal patch in combination therapy for Parkinson\u2019s disease \u2013 observations in routine clinical practice","volume":"27","author":"Ceballos-Baumann","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jsmc.2025.05.003_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.sleep.2016.01.016","article-title":"Rotigotine May improve sleep architecture in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled polysomnographic study","volume":"21","author":"Pierantozzi","year":"2016","journal-title":"Sleep Med"},{"issue":"13","key":"10.1016\/j.jsmc.2025.05.003_bib12","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1517\/14656566.2011.604031","article-title":"Effect of rotigotine on sleep and quality of life in Parkinson\u2019s disease patients:post hocanalysis of RECOVER patients who were symptomatic at baseline","volume":"12","author":"Ghys","year":"2011","journal-title":"Expet Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.003_bib13","article-title":"Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline","volume":"21","author":"Winkelman","year":"2024","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.jsmc.2025.05.003_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3724148","article-title":"Rotigotine objectively improves sleep in Parkinson\u2019s disease: an open-label pilot study with actigraphic recording","volume":"2016","author":"Calandra-Buonaura","year":"2016","journal-title":"Parkinsons Dis"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.003_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11325-016-1414-0","article-title":"An observational clinical and video-polysomnographic study of the effects of rotigotine in sleep disorder in Parkinson\u2019s disease","volume":"21","author":"Wang","year":"2017","journal-title":"Sleep Breath"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.003_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson\u2019s Disease\u2014an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.jsmc.2025.05.003_bib17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00702-022-02506-4","article-title":"Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson\u2019s disease","volume":"129","author":"Lau","year":"2022","journal-title":"J Neural Transm (Vienna)"},{"issue":"9","key":"10.1016\/j.jsmc.2025.05.003_bib18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.parkreldis.2015.06.012","article-title":"Expert consensus group report on the use of apomorphine in the treatment of Parkinson\u2019s disease \u2013 clinical practice recommendations","volume":"21","author":"Trenkwalder","year":"2015","journal-title":"Parkinsonism Relat Disorders"},{"issue":"5","key":"10.1016\/j.jsmc.2025.05.003_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1474-4422(22)00128-4","article-title":"Apomorphine infusion for improving sleep in Parkinson\u2019s disease","volume":"21","author":"Chaudhuri","year":"2022","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.003_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JPD-2011-11037","article-title":"Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson\u2019s disease compared to conventional therapy: a real life study of non motor effect","volume":"1","author":"Martinez-Martin","year":"2011","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.jsmc.2025.05.003_bib21","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.parkreldis.2016.11.017","article-title":"Practical management of adverse events related to apomorphine therapy","volume":"33","author":"Bhidayasiri","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"10.1016\/j.jsmc.2025.05.003_bib22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JPD-160886","article-title":"Evaluating the efficacy of nocturnal continuous subcutaneous apomorphine infusion in sleep disorders in advanced Parkinson\u2019s disease: the APO-NIGHT study","volume":"6","author":"Fern\u00e1ndez-Pajar\u00edn","year":"2016","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.jsmc.2025.05.003_bib23","article-title":"Continuous subcutaneous apomorphine infusion in the early phase of advanced Parkinson\u2019s disease: a prospective study of 22 patients","volume":"6","author":"Fern\u00e1ndez-Pajar\u00edn","year":"2022","journal-title":"Clin Park Relat Disord"},{"issue":"5","key":"10.1016\/j.jsmc.2025.05.003_bib24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1474-4422(22)00085-0","article-title":"Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson\u2019s disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study","volume":"21","author":"De Cock","year":"2022","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.003_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/mdc3.12350","article-title":"Apomorphine subcutaneous injection for the management of morning Akinesia in Parkinson\u2019s disease","volume":"4","author":"Isaacson","year":"2016","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.003_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(13)70293-X","article-title":"Double-blind, double-dummy, randomized study of continuous intrajejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson\u2019s disease","volume":"13","author":"Olanow","year":"2014","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.003_bib27","article-title":"Non-oral dopaminergic therapies for Parkinson\u2019s disease: current treatments and the future","volume":"2","author":"Ray Chaudhuri","year":"2016","journal-title":"npj Parkinson\u2019s Dis"},{"issue":"7","key":"10.1016\/j.jsmc.2025.05.003_bib28","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/mdc3.13239","article-title":"DUOGLOBE : one-year outcomes in a real-world study of levodopa carbidopa intestinal gel for Parkinson\u2019s disease","volume":"8","author":"Standaert","year":"2021","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.jsmc.2025.05.003_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.parkreldis.2017.09.018","article-title":"Levodopa-carbidopa intestinal gel in advanced Parkinson\u2019s: final results of the GLORIA registry","volume":"45","author":"Antonini","year":"2017","journal-title":"Parkinsonism Relat Disorders"},{"issue":"10","key":"10.1016\/j.jsmc.2025.05.003_bib30","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/mds.22596","article-title":"Intrajejunal levodopa infusion in Parkinson\u2019s disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life","volume":"24","author":"Honig","year":"2009","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.jsmc.2025.05.003_bib31","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3233\/JPD-223295","article-title":"Effects of levodopa-carbidopa intestinal gel on dyskinesia and non-motor symptoms including sleep: results from a meta-analysis with 24-Month Follow-Up","volume":"12","author":"Chaudhuri","year":"2022","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.jsmc.2025.05.003_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2017.02.001","article-title":"Levodopa\/Carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson\u2019s disease: an open-label study","volume":"37","author":"Juh\u00e1sz","year":"2017","journal-title":"Parkinsonism Relat Disorders"},{"issue":"5","key":"10.1016\/j.jsmc.2025.05.003_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2217\/nmt-2020-0021","article-title":"Application of the \u201c5-2-1\u201d screening criteria in advanced Parkinson\u2019s disease: interim analysis of DUOGLOBE","volume":"10","author":"Aldred","year":"2020","journal-title":"Neurodegener Dis Manag"},{"issue":"5","key":"10.1016\/j.jsmc.2025.05.003_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3233\/JPD-225105","article-title":"Levodopa carbidopa intestinal gel in advanced Parkinson\u2019s disease: DUOGLOBE final 3-Year results","volume":"13","author":"Ray Chaudhuri","year":"2023","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"10.1016\/j.jsmc.2025.05.003_bib35","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3233\/JPD-212813","article-title":"Foslevodopa\/foscarbidopa is well tolerated and maintains stable levodopa and carbidopa exposure following subcutaneous infusion","volume":"11","author":"Rosebraugh","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.jsmc.2025.05.003_bib36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.parkreldis.2022.03.012","article-title":"Foslevodopa\/foscarbidopa subcutaneous infusion maintains equivalent levodopa exposure to levodopa-carbidopa intestinal gel delivered to the jejunum","volume":"97","author":"Rosebraugh","year":"2022","journal-title":"Parkinsonism Relat Disorders"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.003_bib37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ana.26073","article-title":"Foslevodopa\/Foscarbidopa: a new subcutaneous treatment for Parkinson\u2019s disease","volume":"90","author":"Rosebraugh","year":"2021","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.jsmc.2025.05.003_bib38","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s40120-023-00533-1","article-title":"Continuous subcutaneous Foslevodopa\/foscarbidopa in Parkinson\u2019s disease: safety and efficacy results from a 12-Month, single-arm, open-label, phase 3 study","volume":"12","author":"Aldred","year":"2023","journal-title":"Neurol Ther"},{"issue":"10","key":"10.1016\/j.jsmc.2025.05.003_bib39","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.3390\/s24103045","article-title":"Parkinson\u2019s kinetigraph for wearable sensor detection of clinically unrecognized early-morning akinesia in Parkinson\u2019s disease: a case report-based observation","volume":"24","author":"Pop\u0142awska-Domaszewicz","year":"2024","journal-title":"Sensors"},{"issue":"11","key":"10.1016\/j.jsmc.2025.05.003_bib40","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.parkreldis.2014.09.013","article-title":"Characterizing motor and non-motor aspects of early-morning off periods in Parkinson\u2019s disease: an international multicenter study","volume":"20","author":"Rizos","year":"2014","journal-title":"Parkinsonism Relat Disorders"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.003_bib41","article-title":"Why do patients with Parkinson\u2019s disease fall? A cross-sectional analysis of possible causes of falls","volume":"1","author":"Schrag","year":"2015","journal-title":"npj Parkinson\u2019s Dis"},{"issue":"3","key":"10.1016\/j.jsmc.2025.05.003_bib42","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3233\/JPD-212979","article-title":"Outcomes impacting quality of life in advanced Parkinson\u2019s disease patients treated with levodopa-carbidopa intestinal gel","volume":"12","author":"Kov\u00e1cs","year":"2022","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"10.1016\/j.jsmc.2025.05.003_bib43","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10072-018-3252-2","article-title":"Relevance of sleep quality on caregiver burden in Parkinson\u2019s disease","volume":"39","author":"Bartolomei","year":"2018","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jsmc.2025.05.003_bib44","article-title":"Improved sleep correlates with improved quality of life and motor symptoms with foslevodopa\/foscarbidopa","author":"Ray Chaudhuri","year":"2024","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.jsmc.2025.05.003_bib45","article-title":"Subcutaneous levodopa: a new engine for the vintage molecule","author":"Pop\u0142awska-Domaszewicz","year":"2024","journal-title":"Neurol Ther"},{"key":"10.1016\/j.jsmc.2025.05.003_bib46","unstructured":"Overview | Foslevodopa\u2013foscarbidopa for treating advanced Parkinson\u2019s with motor symptoms | guidance | NICE, Available at: https:\/\/www.nice.org.uk\/guidance\/ta934 (Accessed January 2025), 2023."},{"issue":"6","key":"10.1016\/j.jsmc.2025.05.003_bib47","doi-asserted-by":"crossref","first-page":"608","DOI":"10.5603\/pjnns.102680","article-title":"Challenges of equitable access to device-aided therapies for advanced Parkinson\u2019s disease in Poland \u2014 expert consensus and treatment recommendations","volume":"58","author":"Pop\u0142awska-Domaszewicz","year":"2024","journal-title":"Neurol Neurochir Pol"},{"issue":"3","key":"10.1016\/j.jsmc.2025.05.003_bib48","doi-asserted-by":"crossref","DOI":"10.1097\/MJT.0000000000001707","article-title":"Levodopa\u2013carbidopa\u2013entacapone intestinal gel in advanced parkinson disease: a multicenter real-life experience","volume":"31","author":"Sz\u00e1sz","year":"2024","journal-title":"Am J Therapeut"},{"issue":"5","key":"10.1016\/j.jsmc.2025.05.003_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(24)00052-8","article-title":"Safety and efficacy of continuous subcutaneous levodopa\u2013carbidopa infusion (ND0612) for Parkinson\u2019s disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial","volume":"23","author":"Espay","year":"2024","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.jsmc.2025.05.003_bib50","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ana.23951","article-title":"Adaptive deep brain stimulation in advanced parkinson disease","volume":"74","author":"Little","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jsmc.2025.05.003_bib51","doi-asserted-by":"crossref","DOI":"10.2174\/1570159X19666210215115718","article-title":"Effects of deep brain stimulation on sleep-wake disturbances in patients with Parkinson\u2019s disease: a narrative review","volume":"19","author":"Jung","year":"2021","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"10.1016\/j.jsmc.2025.05.003_bib52","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1007\/s00415-020-09743-1","article-title":"Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson\u2019s disease","volume":"267","author":"Dafsari","year":"2020","journal-title":"J Neurol"},{"issue":"8","key":"10.1016\/j.jsmc.2025.05.003_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221219","article-title":"Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson\u2019s disease","volume":"14","author":"Choi","year":"2019","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.jsmc.2025.05.003_bib54","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/mds.23862","article-title":"Subthalamic nucleus deep brain stimulation restores normal rapid eye movement sleep in Parkinson\u2019s disease","volume":"26","author":"Nishida","year":"2011","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.003_bib55","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00415-004-0305-7","article-title":"Effects of bilateral subthalamic stimulation on sleep in Parkinson?s disease","volume":"251","author":"Monaca","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.jsmc.2025.05.003_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsx033","article-title":"The impact of subthalamic deep brain stimulation on sleep\u2013wake behavior: a prospective electrophysiological study in 50 parkinson patients","author":"Baumann-Vogel","year":"2017","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.jsmc.2025.05.003_bib57","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/jnnp.72.5.661","article-title":"Sleep symptoms and polysomnographic architecture in advanced Parkinson\u2019s disease after chronic bilateral subthalamic stimulation","volume":"72","author":"Iranzo","year":"2002","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.jsmc.2025.05.003_bib58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.parkreldis.2019.04.001","article-title":"The impact of subthalamic deep brain stimulation on sleep and other non-motor symptoms in Parkinson\u2019s disease","volume":"64","author":"Dulski","year":"2019","journal-title":"Parkinsonism Relat Disorders"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.003_bib59","article-title":"Changes in Parkinson\u2019s disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson\u2019s disease","volume":"4","author":"Kharkar","year":"2018","journal-title":"Npj Parkinson\u2019s Dis"},{"issue":"4","key":"10.1016\/j.jsmc.2025.05.003_bib60","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3171\/jns.2006.104.4.502","article-title":"Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease","volume":"104","author":"Lyons","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jsmc.2025.05.003_bib61","first-page":"1","article-title":"Evaluation of the effect of bilateral subthalamic nucleus deep brain stimulation on fatigue in Parkinson\u2019s disease as measured by the non-motor symptoms scale","author":"Lazcano-Ocampo","year":"2021","journal-title":"Br J Neurosurg"},{"issue":"6","key":"10.1016\/j.jsmc.2025.05.003_bib62","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.003_bib63","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jocn.2014.07.016","article-title":"Rapid eye movement sleep behavior disorder after bilateral subthalamic stimulation in Parkinson\u2019s disease","volume":"22","author":"Kim","year":"2015","journal-title":"J Clin Neurosci"},{"issue":"3","key":"10.1016\/j.jsmc.2025.05.003_bib64","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.parkreldis.2010.11.017","article-title":"Effects of STN DBS for Parkinson\u2019s disease on restless legs syndrome and other sleep-related measures","volume":"17","author":"Chahine","year":"2011","journal-title":"Parkinsonism Relat Disorders"},{"issue":"11","key":"10.1016\/j.jsmc.2025.05.003_bib65","doi-asserted-by":"crossref","first-page":"e1013","DOI":"10.1212\/WNL.0000000000006162","article-title":"Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease","volume":"91","author":"Klepitskaya","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jsmc.2025.05.003_bib66","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.20349","article-title":"Deep brain stimulation of the GPi treats restless legs syndrome associated with dystonia","volume":"20","author":"Okun","year":"2005","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.003_bib67","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.21631","article-title":"Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons","volume":"66","author":"Lim","year":"2009","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.jsmc.2025.05.003_bib68","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/ner.12442","article-title":"A pilot study assessing the effects of pallidal deep brain stimulation on sleep quality and polysomnography in Parkinson\u2019s patients","volume":"19","author":"Tolleson","year":"2016","journal-title":"Neuromodulation"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.003_bib69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00002826-198205020-00003","article-title":"Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis","volume":"5","author":"Nausieda","year":"1982","journal-title":"Clin Neuropharmacol"},{"issue":"7","key":"10.1016\/j.jsmc.2025.05.003_bib70","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/jnnp-2019-322614","article-title":"A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson\u2019s disease: results at the 36-month follow-up","volume":"91","author":"Jost","year":"2020","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.003_bib71","doi-asserted-by":"crossref","DOI":"10.33425\/2690-8077.1102","article-title":"Gastrointestinal manifestations of Parkinson\u2019s disease survey of the recent literature","volume":"5","author":"Hookman","year":"2024","journal-title":"Japan J Research"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.003_bib72","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.psych.56.091103.070307","article-title":"Sleep, memory, and plasticity","volume":"57","author":"Walker","year":"2006","journal-title":"Annu Rev Psychol"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.003_bib73","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1152\/physrev.00032.2012","article-title":"About sleep\u2019s role in memory","volume":"93","author":"Rasch","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jsmc.2025.05.003_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","author":"Xie","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.003_bib75","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mds.30064","article-title":"Low-frequency deep brain stimulation in non-rapid eye movement sleep modifies memory retention in Parkinson\u2019s disease","volume":"40","author":"Herz","year":"2025","journal-title":"Mov Disord"}],"container-title":["Sleep Medicine Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556407X2500030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556407X2500030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T01:02:11Z","timestamp":1756947731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556407X2500030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1556407X2500030X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsmc.2025.05.003","relation":{},"ISSN":["1556-407X"],"issn-type":[{"type":"print","value":"1556-407X"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal, Infusion, and Surgical Therapies and Effect on Sleep Dysfunction in Parkinson\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsmc.2025.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}